The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
770
July 15, 1988
View Complete Issue         Table of Contents 2019 
Interferon Treatment of Genital Warts
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Interferon Treatment of Genital Warts
July 15, 1988 (Issue: 770)
Recombinant interferon alfa-2b (Intron A - Schering) was recently approved by the US Food and Drug Administration (FDA) for intralesional treatment of genital warts (condylomata acuminata). Interferon was previously available only for treatment of ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Interferon Treatment of Genital Warts
Article code: 770b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.